We are live on ! Find out more
LYFE

2ndVote Life Neutral Plus ETF

Delisted

LYFE was delisted on the 3rd of August, 2023.

8 hedge funds and large institutions have $917K invested in 2ndVote Life Neutral Plus ETF in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

60% more funds holding

Funds holding: 58 (+3)

34% less capital invested

Capital invested by funds: $1.4M → $917K (-$478K)

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

LYFE Hedge Fund Activity: Q2 2022 in Review

8 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in 2ndVote Life Neutral Plus ETF (LYFE) for Q2 2022, worth a combined $917K — down 34% from $1.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new LYFE positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $352K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1.38M sold.

  • 8 institutional investors held 2ndVote Life Neutral Plus ETF (LYFE) as of Q2 2022, up from 5 in Q1 2022.
  • Funds reported $917K of 2ndVote Life Neutral Plus ETF stock for Q2 2022, down 34% quarter-over-quarter.
  • 4 funds opened new 2ndVote Life Neutral Plus ETF positions in Q2 2022 and 1 closed out, a net change of +3 holders.
  • The largest 2ndVote Life Neutral Plus ETF buyer in Q2 2022 was Citadel Advisors, an estimated $352K added.
  • The largest 2ndVote Life Neutral Plus ETF seller in Q2 2022 was Tower Research Capital (TRC), an estimated $1.38M sold.

Based on aggregated 13F filings for Q2 2022.